Jonathan Rubin - Feb 23, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: SVP, Chief Medical Officer
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Feb 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/27/2023, 04:03 PM
Previous filing: Feb 24, 2023
Next filing: Dec 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						2.5K	Feb 23, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Employee Stock Option (Right to Buy)	Award	$0	+20K		$0.00	20K	Feb 23, 2023	Common Stock	20K	$38.60	Direct	F1
transaction	SUPN	Restricted Stock Units	Award	$0	+5K		$0.00	5K	Feb 23, 2023	Common Stock	5K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in four equal annual installments beginning on February 23, 2024.
F2	Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3	These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024.